IESLAB(SZ:002339)2024-04-29 10:54Revenue and Profitability - Revenue for Q1 2024 was CNY 250,782,245.68, an increase of 18.51% compared to CNY 211,616,763.55 in the same period last year[5] - Net loss for Q1 2024 was CNY 82,271,736.87, compared to a net loss of CNY 71,181,135.95 in the same period last year[19] - The company reported a gross profit margin decline due to rising costs, with gross profit at CNY 78,748,120.57, down from CNY 63,844,787.82[18] - Basic and diluted earnings per share were both negative CNY 0.16, compared to negative CNY 0.14 in the previous year[19] Cash Flow - Net cash flow from operating activities was CNY -134,428,597.14, an improvement of 6.78% compared to CNY -144,200,375.80 in the previous year[5] - Operating cash flow for the period was negative CNY 134,428,597.14, slightly improved from negative CNY 144,200,375.80 in the previous year[20] - Cash received from operating activities totaled CNY 566,094,200.42, compared to CNY 552,283,641.92 in the prior year[20] - Cash inflow from financing activities totaled ¥268,842,063.84, compared to ¥116,830,000.00 in the previous year, representing an increase of 130%[21] - Cash outflow from financing activities amounted to ¥278,189,889.90, up from ¥59,887,593.92, indicating a significant rise of 365%[21] - The net cash flow from financing activities was -¥9,347,826.06, contrasting with a positive net cash flow of ¥56,942,406.08 in the same period last year[21] - The net increase in cash and cash equivalents was -¥145,559,077.51, compared to -¥93,189,991.86 in the previous year, reflecting a worsening cash position[21] - The ending balance of cash and cash equivalents was ¥633,602,785.50, slightly down from ¥632,462,071.56 year-over-year[21] Assets and Liabilities - Total assets decreased by 6.80% to CNY 3,930,984,650.28 from CNY 4,217,996,288.91 at the end of the previous year[5] - Cash and cash equivalents decreased from CNY 850,721,894.67 to CNY 681,778,959.29, a reduction of about 20%[15] - Accounts receivable decreased from CNY 1,398,050,485.56 to CNY 1,129,097,443.75, reflecting a decrease of approximately 19.3%[15] - Inventory increased from CNY 557,073,711.41 to CNY 664,810,806.91, an increase of about 19.2%[15] - Current liabilities decreased from CNY 1,825,044,459.20 to CNY 1,416,319,956.19, a reduction of approximately 22.5%[16] - Long-term borrowings increased from CNY 218,500,000.00 to CNY 423,260,000.00, an increase of about 93.8%[16] - The total liabilities decreased from CNY 2,093,499,768.64 to CNY 1,888,430,706.39, a decline of approximately 9.8%[16] - The company's retained earnings decreased from CNY 743,137,175.81 to CNY 661,962,037.41, a decrease of about 10.9%[16] - The total equity remained stable at CNY 2,042,553,943.89, with a slight increase in capital reserves from CNY 448,621,264.70 to CNY 448,843,439.79[16] - The company reported a significant reduction in short-term loans from CNY 267,200,000.00 to CNY 226,030,000.00, a decrease of approximately 15.4%[16] Research and Development - R&D expenses increased by 38.44% year-over-year, primarily due to higher labor costs and product testing expenses[8] - Research and development expenses increased to CNY 52,893,125.33, compared to CNY 38,205,925.17 in the prior year[18] Investment Income - The company reported a net investment income increase of 42.29% year-over-year, attributed to higher returns from financial products[8] - The company recorded investment income of CNY 6,286,117.80, an increase from CNY 4,417,779.64 in the previous period[18] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 53,400[10] - The largest shareholder, Shandong State-owned Assets Investment Holdings Co., Ltd., held a 10.38% stake in the company[10]